DK98581A - Middel med fibronectin-lignende aktivitet og fremgangsmaade til dets fremstilling - Google Patents

Middel med fibronectin-lignende aktivitet og fremgangsmaade til dets fremstilling

Info

Publication number
DK98581A
DK98581A DK98581A DK98581A DK98581A DK 98581 A DK98581 A DK 98581A DK 98581 A DK98581 A DK 98581A DK 98581 A DK98581 A DK 98581A DK 98581 A DK98581 A DK 98581A
Authority
DK
Denmark
Prior art keywords
fibronectin
activity
procedure
preparation
isolating
Prior art date
Application number
DK98581A
Other languages
English (en)
Other versions
DK156697B (da
DK156697C (da
Inventor
D G Wallace
P M Schneider
J L Lundblad
Original Assignee
Cutter Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cutter Lab filed Critical Cutter Lab
Publication of DK98581A publication Critical patent/DK98581A/da
Publication of DK156697B publication Critical patent/DK156697B/da
Application granted granted Critical
Publication of DK156697C publication Critical patent/DK156697C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK098581A 1980-03-05 1981-03-04 Fremgangsmaade til separering og isolering af antihaemofil faktor og fibronectin fra en blodplasmaproeve DK156697C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/127,340 US4341764A (en) 1980-03-05 1980-03-05 Method of preparing fibronectin and antihemophilic factor
US12734080 1980-03-05

Publications (3)

Publication Number Publication Date
DK98581A true DK98581A (da) 1981-09-06
DK156697B DK156697B (da) 1989-09-25
DK156697C DK156697C (da) 1990-02-05

Family

ID=22429606

Family Applications (1)

Application Number Title Priority Date Filing Date
DK098581A DK156697C (da) 1980-03-05 1981-03-04 Fremgangsmaade til separering og isolering af antihaemofil faktor og fibronectin fra en blodplasmaproeve

Country Status (9)

Country Link
US (1) US4341764A (da)
EP (1) EP0035202B1 (da)
JP (1) JPS56139418A (da)
AT (1) ATE15973T1 (da)
CA (1) CA1164342A (da)
DE (1) DE3172567D1 (da)
DK (1) DK156697C (da)
ES (1) ES8202029A1 (da)
MX (1) MX7113E (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPS584074U (ja) * 1981-06-30 1983-01-11 井上　岱介 風車ネオン式検電器
DE3170868D1 (en) * 1981-10-12 1985-07-11 Armour Pharma Process for the preparation of highly purified antihemophilic factor
US4391749A (en) * 1981-10-19 1983-07-05 La Jolla Cancer Research Foundation Method for the purification of collagens
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
JPS59134732A (ja) * 1983-01-21 1984-08-02 Green Cross Corp:The フイブロネクチン・生理活性物質複合体の製造法
DE3318521A1 (de) * 1983-05-20 1984-11-22 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats
DE3485773T2 (de) * 1983-11-04 1993-02-11 Ralph Silverman Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten.
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
AT385658B (de) * 1985-03-28 1988-05-10 Serotherapeutisches Inst Wien Verfahren zur herstellung einer fuer die anwendung beim menschen geeigneten fibronektinloesung
US4587122A (en) * 1985-04-23 1986-05-06 The Green Cross Corporation Fibronectin-dextran-drug complex and method of preparation thereof
US4894328A (en) * 1986-03-26 1990-01-16 Board Of Regents, The University Of Texas System Immunodiagnostic test for syphilis and other treponemal infections
DK475386D0 (da) 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
US5453489A (en) * 1992-01-31 1995-09-26 La Jolla Cancer Research Foundation Polypeptide fragments of fibronectin which can modulate extracellular matrix assembly
US5629291A (en) * 1992-01-31 1997-05-13 La Jolla Cancer Research Foundation Methods of modulating fibronectin extracellular matrix assembly
US7112320B1 (en) * 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
US5821220A (en) * 1995-06-07 1998-10-13 Andre Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US6528483B2 (en) * 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
EP1049716A4 (en) * 1998-01-23 2002-07-03 Csl Ltd PURIFICATION OF FIBRINOGEN
CA2634664C (en) 1999-02-22 2011-08-09 University Of Connecticut Novel albumin-free factor viii formulations
ES2327208T3 (es) * 1999-12-23 2009-10-27 Csl Limited Separacion de fibrinogeno de proteasas de plasma.
AU779126B2 (en) * 1999-12-23 2005-01-06 Csl Limited Separation of fibrinogen from plasma proteases
DE102004044419B4 (de) 2004-09-14 2010-04-15 Biotest Ag Verfahren zur Aufreinigung eines von Willebrand Faktors mittels Hydroxylapatit-Durchlaufchromatographie
DE102004044429B4 (de) * 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations
MA33368B1 (fr) 2009-05-25 2012-06-01 Lundbeck & Co As H Préparation de chlorhydrate de nalmefene à partir de naltrexone
IL213864A0 (en) 2011-06-30 2011-08-31 Omrix Biopharmaceuticals Ltd Method for removing a lytic enzyme from a heterogeneous mixture
US8844879B2 (en) * 2011-12-12 2014-09-30 The Boeing Company Wing variable camber trailing edge tip
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
DE2848529A1 (de) * 1978-11-09 1980-05-29 Behringwerke Ag Verfahren zur herstellung des kaelteunloeslichen globulins und dieses enthaltende arzneimittel
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma

Also Published As

Publication number Publication date
JPS56139418A (en) 1981-10-30
EP0035202A3 (en) 1982-09-01
DE3172567D1 (en) 1985-11-14
CA1164342A (en) 1984-03-27
DK156697B (da) 1989-09-25
MX7113E (es) 1987-06-29
ES500122A0 (es) 1982-01-01
ATE15973T1 (de) 1985-10-15
EP0035202B1 (en) 1985-10-09
DK156697C (da) 1990-02-05
US4341764A (en) 1982-07-27
EP0035202A2 (en) 1981-09-09
ES8202029A1 (es) 1982-01-01

Similar Documents

Publication Publication Date Title
DK98581A (da) Middel med fibronectin-lignende aktivitet og fremgangsmaade til dets fremstilling
DK590085D0 (da) Bicycliske heteroarylpiperazinderivater og fremgangsmaade til deres fremstilling
ES8400409A1 (es) "un procedimiento de preparacion de nuevas carboxamidas heterociclicas".
DK2285D0 (da) Osteogen faktor og middel indeholdende denne faktor
ES8704546A1 (es) Metodo de produccion de una proteina con actividad procoagu-lante del tipo de factor viii:c humano
DK93685D0 (da) Benzisoselenazolthioner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
ES8606286A1 (es) Procedimiento para preparar nuevos derivados de benzazocinona y de benzazoninona
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
DK120284A (da) Fremgangsmaade til fermentering af en enzymproducerende mikroorganisme, der kan producere protease og amylase
PT73214A (en) Process for preparing modified glucosaminoglucans having antilipemic activity and essentially devoid of anticoagulant activity
DK565485D0 (da) Fremgangsmaade og apparat til frembringelse af en bue af plasma
IT8149801A0 (it) Procedimento per la produzione di urochinasi umana
MY132553A (en) Methods of making hiv-protease inhibitors and intermediates for making hiv-protease inhibitors
DK506683A (da) Fibrinolytiske enzymer, fremgangsmaader til fremstilling deraf og farmaceutiske midler indeholdende dem
DK155910C (da) Apparat til samtidig, cutan bestemmelse af partialtrykket af gasser i blodet og blodgasperfusionen
ZA877434B (en) Use of urokinase(uk)for lysing fibrin blood clots
HUT76881A (en) Purification of vitamin-k dependent plasma compnents, protein c and protein s by membrane chromatography
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
ES436513A1 (es) Un metodo para purificar extractos que contienen utero-eva- cuantes obtenidos a partir de la planta zoapatle.
NO842468L (no) Ny plasminogenaktivator, fremgangsmaate for fremstilling av denne og trombolytisk middel inneholdende denne
NO885777L (no) Fremgangsmaate for rensing av granulocytt/makrofagkolonistimulerendefaktor.
SU697563A1 (ru) Питательна среда дл выделени микроорганизмов-продуцентов амилаз
DK165597C (da) Fremgangsmaade til at fremme udskillelse af amylolytiske enzymer fra bakterier
HUT34950A (en) Process for the production of alpha-allene-alpha-amino acids and of therapeutic preparations containing such agents
YU329775A (en) Process for the isolation of the thrombine like enzyme from the bothrops asper venom

Legal Events

Date Code Title Description
PBP Patent lapsed